Emerging and Re-emerging Respiratory Viruses

Dear Colleagues,

Infectious diseases are still the main cause of human morbidity and mortality, leading to outbreaks and epidemics. In the last century, influenza, severe acute respiratory syndrome coronavirus, and the Middle East respiratory syndrome coronavirus were the most damaging respiratory infections for humans worldwide. These emerging viral respiratory infections derived from the animal world. Emerging viruses, particularly RNA viruses, can adapt to the rapidly changing global and local environments due to the high error rate of their polymerases. Mutations in the genetic material of RNA viruses accumulate in years and produce new strains of the viruses with new antigenic properties resulting in transmission in humans. The probability of pandemics with new viruses would be high in the future as this type of mutation will reoccur. This Special Issue of Microorganisms seeks to attract original research and review articles focused on (1) the development of diagnostic tests for the early detection of human respiratory viruses; (2) findings on the epidemiology and transmission of human respiratory viruses; (3) the development of new vaccines, antivirals, immunotherapeutics, and/or drug repositioning for respiratory viruses; and (4) virus/host interaction.

Dr. Antonella Bugatti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antiviral
• vaccine
• respiratory viral infection
• inhibitors
• SARS-CoV-2